Noveris Health Sciences is trading 11.11% lower at CA$0.04 on November 3, 2026, with no company-specific catalyst identified. - Biotechnology shares are down 2.39%; this may be contributing, but does not establish a specific catalyst for the larger move. - Search results show no company-specific announcement dated November 3; the most recent surfaced company news is older, including September’s annual meeting results. - Broad-market signals are mixed; no trading-volume data was provided.